Chennai: Authorities have detected adulteration in samples of cough syrups produced by a city-based pharmaceutical company, prompting an immediate halt in production and intensifying regulatory action after recent child deaths in Madhya Pradesh and Rajasthan.

Officials from the Tamil Nadu Food Safety and Drug Administration (FSDA) confirmed that test results of syrups collected during an inspection at the firm's manufacturing unit in Sunguvarchathram, Kancheepuram district, revealed the medicines were adulterated.

The company has been ordered to explain the findings and cease production until further notice.

The crackdown follows the Tamil Nadu government's statewide ban on the cough syrup brand Coldrif, enforced from October 1, after concerns that the medicine may have been linked to

See Full Page